IL39341A - Thieno(3,2-d)pyrimidines,their preparation and pharmaceutical compositions containing them - Google Patents

Thieno(3,2-d)pyrimidines,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL39341A
IL39341A IL39341A IL3934172A IL39341A IL 39341 A IL39341 A IL 39341A IL 39341 A IL39341 A IL 39341A IL 3934172 A IL3934172 A IL 3934172A IL 39341 A IL39341 A IL 39341A
Authority
IL
Israel
Prior art keywords
thieno
pyrimidines
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL39341A
Other languages
English (en)
Other versions
IL39341A0 (en
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19712121950 external-priority patent/DE2121950A1/de
Priority claimed from DE19712137341 external-priority patent/DE2137341A1/de
Priority claimed from DE19722215299 external-priority patent/DE2215299A1/de
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of IL39341A0 publication Critical patent/IL39341A0/xx
Publication of IL39341A publication Critical patent/IL39341A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL39341A 1971-05-04 1972-05-03 Thieno(3,2-d)pyrimidines,their preparation and pharmaceutical compositions containing them IL39341A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19712121950 DE2121950A1 (en) 1971-05-04 1971-05-04 Thieno(3,2-d)pyrimidine derivs - with thrombocyte aggregation inhibiting activity
DE19712137341 DE2137341A1 (de) 1971-07-26 1971-07-26 Neue thieno eckige klammer auf 3,2-d eckige klammer zu pyrimidine
DE19722215299 DE2215299A1 (de) 1972-03-29 1972-03-29 Neue thieno eckige klammer auf 3,2-d eckige klammer zu pyrimidine

Publications (2)

Publication Number Publication Date
IL39341A0 IL39341A0 (en) 1972-07-26
IL39341A true IL39341A (en) 1975-08-31

Family

ID=27183398

Family Applications (1)

Application Number Title Priority Date Filing Date
IL39341A IL39341A (en) 1971-05-04 1972-05-03 Thieno(3,2-d)pyrimidines,their preparation and pharmaceutical compositions containing them

Country Status (15)

Country Link
US (1) US3888851A (de)
AT (1) AT318619B (de)
AU (1) AU4181572A (de)
BE (1) BE783044A (de)
BG (1) BG20593A3 (de)
DD (1) DD97656A5 (de)
DK (1) DK129844B (de)
ES (1) ES402302A1 (de)
FR (1) FR2135294B1 (de)
GB (1) GB1393161A (de)
HU (1) HU163960B (de)
IL (1) IL39341A (de)
NL (1) NL7206041A (de)
PL (1) PL82381B1 (de)
RO (1) RO62428A (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4054656A (en) * 1975-09-10 1977-10-18 Mead Johnson & Company Thieno[2,3-d]pyrimidine antiallergic agents
US5098902A (en) * 1991-03-18 1992-03-24 Warner-Lambert Company Method of treating neurodegenerative diseases
FI943798A7 (fi) * 1992-02-19 1994-08-18 Pfizer Kasvaimenvastaisen vaikutuksen lisäämiseen tarkoitettuja heterosyklisi ä yhdisteitä
KR100378937B1 (ko) 1997-10-20 2003-05-09 에프. 호프만-라 로슈 아게 바이사이클릭 키나아제 억제제
US6187777B1 (en) 1998-02-06 2001-02-13 Amgen Inc. Compounds and methods which modulate feeding behavior and related diseases
GB0423653D0 (en) 2004-10-25 2004-11-24 Piramed Ltd Pharmaceutical compounds
JP5021624B2 (ja) * 2005-04-21 2012-09-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 炎症性疾患の治療用新規化合物
TWI409268B (zh) 2006-04-26 2013-09-21 Hoffmann La Roche 醫藥化合物
EP2041139B1 (de) 2006-04-26 2011-11-09 F. Hoffmann-La Roche AG Pharmazeutische verbindungen
WO2007127183A1 (en) 2006-04-26 2007-11-08 Genentech, Inc. Phosphoinositide 3-kinase inhibitor compounds and pharmaceutical compositions containing them
JP5284977B2 (ja) * 2006-12-07 2013-09-11 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト ホスホイノシチド３−キナーゼ阻害剤化合物及び使用方法
PE20081353A1 (es) 2006-12-07 2008-11-12 Hoffmann La Roche Compuestos del inhibidor de fosfoinositida 3-cinasa
WO2009042607A1 (en) 2007-09-24 2009-04-02 Genentech, Inc. Thiazolopyrimidine p13k inhibitor compounds and methods of use
CN101827853A (zh) * 2007-10-19 2010-09-08 贝林格尔.英格海姆国际有限公司 杂环取代的哌嗪子基-二氢噻吩并嘧啶
ES2439705T3 (es) 2007-10-25 2014-01-24 Genentech, Inc. Proceso para la preparación de compuestos de tienopirimidina
GB0721095D0 (en) 2007-10-26 2007-12-05 Piramed Ltd Pharmaceutical compounds
BRPI1006189A2 (pt) 2009-03-12 2020-08-18 Genentech Inc uso de uma combinação terapêutica, formulação farmacêutica, artigo de manufatura, produto, método para determinar compostos a serem utilizados em combinação para o tratamento de uma malignidade hematopoiética e método para selecionar compostos a serem utilizados em combinação para o tratamento de câncer
BRPI1009022A2 (pt) 2009-05-27 2016-03-08 Hoffmann La Roche "composto, composição farmacêutica, processo para produzir uma composição farmacêutica, uso de um composto, método para tratamento de uma doença ou transtorno e kit"
SG182247A1 (en) * 2009-05-27 2012-08-30 Hoffmann La Roche Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
CN103038643A (zh) 2010-04-16 2013-04-10 基因泰克公司 作为pi3k/akt激酶途径抑制剂效能的预测性生物标记的foxo3a
WO2012088254A1 (en) 2010-12-22 2012-06-28 Genentech, Inc. Autophagy inducer and inhibitor combination therapy for the treatment of neoplasms
KR102182488B1 (ko) 2013-02-25 2020-11-24 제넨테크, 인크. 약물 내성 akt 돌연변이체의 검출 및 치료를 위한 방법 및 조성물
GB201410816D0 (en) * 2014-06-17 2014-07-30 Ucb Biopharma Sprl And Katholieke Universiteit Leuven Therapeutic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3259623A (en) * 1963-06-14 1966-07-05 Olin Mathieson Process for preparing 2-(secondary amino)-halogenopyrimidines
DE1470356A1 (de) * 1964-01-15 1970-04-30 Thomae Gmbh Dr K Neue Thieno[3,2-d]pyrimidine und Verfahren zu ihrer Herstellung
US3210368A (en) * 1964-09-29 1965-10-05 Ciba Geigy Corp Certain 2-amino-4-aryl-5-n, n-disubstituted amino-lower alkyl-thiazole compounds

Also Published As

Publication number Publication date
DK129844B (da) 1974-11-25
FR2135294B1 (de) 1975-10-17
AT318619B (de) 1974-11-11
IL39341A0 (en) 1972-07-26
HU163960B (de) 1973-11-28
GB1393161A (en) 1975-05-07
BG20593A3 (bg) 1975-12-05
FR2135294A1 (de) 1972-12-15
AU4181572A (en) 1973-11-08
NL7206041A (de) 1972-11-07
BE783044A (fr) 1972-11-06
ES402302A1 (es) 1975-04-01
RO62428A (fr) 1978-01-15
DD97656A5 (de) 1973-05-12
DK129844C (de) 1975-05-12
PL82381B1 (de) 1975-10-31
US3888851A (en) 1975-06-10

Similar Documents

Publication Publication Date Title
IL39341A (en) Thieno(3,2-d)pyrimidines,their preparation and pharmaceutical compositions containing them
IL38687A (en) Omega-imidazolyl-omega-phenoxy-alkanones,their preparation and pharmaceutical compositions containing them
IL45492A0 (en) New pyrimidines,their preparation and pharmaceutical compositions containing them
IL36079A0 (en) 4-morpholino-thieno (3,2-d) pyrimidine derivatives,their production and pharmaceutical compositions containing them
IL35729A (en) 2-(5-nitro-2-furyl)-thieno(3,2-d) pyrimidines,their preparation and pharmaceutical compositions containing them
IL35688A0 (en) Substituted n-allyl-2-arylamino-imidazolines-(2),their preparation and pharmaceutical compositions containing them
IL35078A (en) 2-aminoalkylamino-thieno (3,2-d) pyrimidines and their salts,their preparation and pharmaceutical compositions containing them
IL39080A (en) Adenosine derivatives,their preparation and compositions containing them
IL40184A0 (en) 5-cinnamoyl-benzofurans,their preparation and pharmaceutical compositions containing them
IL39845A0 (en) Novel quinazolinone derivatives,their preparation and pharmaceutical compositions containing them
IL40800A0 (en) Thiazolo(5,4-d)pyrimidines,their preparation and pharmaceutical compositions containing them
IL40572A0 (en) Biphenylyl-butanols,their preparation and pharmaceutical compositions containing them
IL40559A0 (en) Novel pyrido(2,3-d)pyrimidines their preparation and pharmaceutical compositions containing them
IL41035A (en) N-lysergyl-3'-amino-pyridine derivatives,their production and pharmaceutical compositions containing them
IL40458A0 (en) Novel pyrimidinones and hydroxypyrimidines,their preparation and pharmaceutical compositions containing them
IL35689A (en) 2-arylamino-imidazolines-(2),their preparation and pharmaceutical compositions containing them
IL39173A0 (en) 2-(5-nitro-2-furyl)-thieno(2,3-d)pyrimidines and salts thereof,their preparation and pharmaceutical compositions containing them
IL40886A0 (en) Novel benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them
IL40362A0 (en) Novel 4-oxo-4h-1-benzopyran and-thiabenzopyran derivatives,their preparation and pharmaceutical compositions containing them
IL41200A0 (en) Substituted 3-amino-prop-1-enes,their preparation and pharmaceutical compositions containing them
IL38593A (en) Substituted 2-arylamino-imidazoline-(2)derivatives,their preparation and pharmaceutical compositions containing them
IL33821A (en) 1,3-dihydro-5-phenyl or pyridyl-2h-1,4-benzodiazepin-2-onederivatives,their preparation and pharmaceutical compositions containing them
IL40017A0 (en) Pyrimidine derivatives,their preparation and pesticidal compositions containing them
IL39355A0 (en) Androstan-17beta-yl-acrylonitrile derivatives,their preparation and pharmaceutical compositions containing them
IL39381A0 (en) Rheadan-type alkaloids,their preparation and pharmaceutical compositions containing them